Co-occurring conditions

When depression comes with PTSD

By the editorial team - Reviewed for plain-language accuracy

Depression and post-traumatic stress disorder often travel together. Many people who have carried trauma also live with a depression that refuses to lift, and it can be hard to tell where one ends and the other begins. If your antidepressants have not worked and you also recognize signs of PTSD, it helps to understand how the two conditions relate, which treatments are approved for which problem, and how a good plan can address both without confusing them.

Why the two overlap so often

Trauma changes how the brain handles stress, sleep, and mood, and it raises the risk of developing depression. Meanwhile, depression can deepen the isolation and hopelessness that make PTSD symptoms harder to manage. The two share overlapping experiences, such as poor sleep, loss of interest, trouble concentrating, and a flattened sense of the future, which is one reason a single medication aimed only at depression sometimes leaves a person still struggling. When depression sits on top of untreated trauma, treating just half the picture rarely feels like enough.

What is approved for depression

If your depression has met the treatment-resistant threshold, the established next-line options apply. Esketamine (Spravato) is FDA-approved for treatment-resistant depression and works on a different brain system than standard antidepressants. TMS is FDA-cleared for depression that has not responded to medication. Both can address the depression side of a combined picture, and both are covered by many insurance plans, including MO HealthNet, when medical criteria are met. Our guide to the approved next-line treatments covers these in more depth.

What is established for PTSD

PTSD has its own evidence-based treatments, and they are worth knowing by name so you can ask for them:

• Trauma-focused therapy has the strongest evidence for PTSD. This includes prolonged exposure, cognitive processing therapy, and eye movement desensitization and reprocessing (EMDR). These are structured, time-limited approaches, not open-ended talk.
• Medication for PTSD: two antidepressants, sertraline and paroxetine, are FDA-approved specifically for PTSD, and clinicians sometimes use others off-label based on the individual.
• Emerging options: research into treatments like ketamine and TMS for PTSD is active, and some clinics offer them, but it is important to understand when a treatment is being used for its approved purpose versus off-label. A clinician should be clear about that with you.

A note on esketamine and ketamine for PTSD

This is where accuracy matters. Esketamine (Spravato) is approved for depression, not for PTSD. When someone has both conditions, esketamine may be used to treat the depression while the PTSD is addressed with treatments established for it. You may also read about ketamine being studied for PTSD; the early research is of interest, but it is not the same as an approved PTSD treatment, and it should only ever happen under qualified medical supervision. Being clear-eyed about this protects you from overstated claims.

Treating both, on purpose

The most effective plans are usually the ones that name both problems and treat both. That might look like a biological treatment for the depression, such as esketamine or TMS, paired with a trauma-focused therapy for the PTSD, coordinated by a team that talks to itself. Improvement in one condition often makes the other easier to work on. As with depression alone, progress is typically a slope rather than a switch, measured over weeks, and worth tracking honestly with your care team.

If you see yourself in both descriptions, that recognition is useful information, not a heavier diagnosis to fear. It points toward a fuller plan. Bring it to a clinician plainly: the depression has not responded, and trauma is part of the story. That honesty is often where a genuinely better plan begins.

Keep reading